To Dynamically Monitor the Anti-Interferon-γ Autoantibodies on Talaromycosisis in Human Immunodeficiency Virus-negative Recruiting Phase Trials for Voriconazole (DB00582)

IndicationStatusPhase
DBCOND0117298 (To Dynamically Monitor the Anti-Interferon-γ Autoantibodies on Talaromycosisis in Human Immunodeficiency Virus-negative)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03827278Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole TherapyTreatment